← Eichor
Study identifier: NCT07594158 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study to Evaluate the Safety, Efficacy, and PK of ONO-2017 in Japanese Patients With POS 2 to 17 Year Olds

Condition: Partial Epilepsy  ·  Sponsor: Ono Pharmaceutical Co., Ltd.

PhasePhase 3
Planned participants20
Who can joinAll sexes, 2 Years to 17 Years
Healthy volunteersNo

About this study

Primary objective: To evaluate the safety and tolerability of cenobamate in Japanese pediatric subjects 2-17 years of age with partial-onset (focal) seizures

This description comes directly from the study's public registry record.

Talk to the study team

North America Clinical Trial Support Desk  ·  +18665877745 (Toll-Free)  ·  clinical_trial@ono-pharma.com

International Clinical Trial Support Desk  ·  +17162141777 (Standard)  ·  clinical_trial@ono-pharma.com

Always discuss trial participation with your own doctor first.

Locations (1)

Japan Red Cross Fukuoka HospitalFukuoka, JapanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07594158